Document is current
Any future updates will be listed below
-
Authors
Jacob, Saiju https://orcid.org/0000-0003-0037-454X
- License Information
-
More Information
Article History
Received: 2 January 2024
Revised: 17 February 2024
Accepted: 7 May 2024
First Online: 24 May 2024
Competing interests
: SJ has served as an international advisory board member for Alexion, Alnylam, Argenx, Janssen, Immunovant, Regeneron and UCB pharmaceuticals, is currently an expert panel member of Myasthenia Gravis consortium for Argenx pharmaceuticals and has received speaker fees from Argenx, Eisai, Terumo BCT and UCB pharmaceuticals. He is also a board member (trustee) of the UK myasthenia patient charity, Myaware.
